Jennifer Gottwald
InsideSources, 4/24/2023...
Walter G. Copan
RealClearHealth, 4/19/2023...
Adam Lidgett
Law360, 3/22/2023...
Brenda Sandburg
The Pink Sheet, 3/22/2023...
Ed Silverman
STAT, 3/22/2023...
Alex Ruoff
Bloomberg Government, 3/22/2023...
WASHINGTON, D.C. (March 21, 2023) --Today, in response to the NIH's just-announced decision to reject activists' requests for the federal government to misuse "march-in" rights under the Bayh-Dole Act against the successfully developed prostate cancer drug Xtandi, Executive Director of the Bayh-Dole Coalition Joseph P. Allen released the following statement: ...
Vital Health Podcast, 3/2/2023...